FDA NDC Directory · JSON-LD · Markdown
NDC 65219-656 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Labeler / Manufacturer | Fresenius Kabi USA, LLC |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA212832 |
| Dosage form / route | INJECTION, SOLUTION · INTRAVENOUS |
| Active ingredients | DIBASIC POTASSIUM PHOSPHATE (11.8 mg/mL) MONOBASIC POTASSIUM PHOSPHATE (11.2 mg/mL) |
| Marketing started | 20250615 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).